These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23031404)

  • 1. Peripheral PDLIM5 expression in bipolar disorder and the effect of olanzapine administration.
    Zain MA; Jahan SN; Reynolds GP; Zainal NZ; Kanagasundram S; Mohamed Z
    BMC Med Genet; 2012 Oct; 13():91. PubMed ID: 23031404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression in the peripheral leukocytes and association analysis of PDLIM5 gene in schizophrenia.
    Numata S; Ueno S; Iga J; Yamauchi K; Hongwei S; Hashimoto R; Takeda M; Kunugi H; Itakura M; Ohmori T
    Neurosci Lett; 2007 Mar; 415(1):28-33. PubMed ID: 17287082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive association between the PDLIM5 gene and bipolar disorder in the Chinese Han population.
    Zhao T; Liu Y; Wang P; Li S; Zhou D; Zhang D; Chen Z; Wang T; Xu H; Feng G; He L; Yu L
    J Psychiatry Neurosci; 2009 May; 34(3):199-204. PubMed ID: 19448850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental evidence for the involvement of PDLIM5 in mood disorders in hetero knockout mice.
    Horiuchi Y; Ishikawa M; Kaito N; Iijima Y; Tanabe Y; Ishiguro H; Arinami T
    PLoS One; 2013; 8(4):e59320. PubMed ID: 23593136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case-control association study of the PDLIM5 gene and bipolar disorder in a Sardinian sample.
    Squassina A; Manchia M; Manconi F; Piccardi M; Ardau R; Chillotti C; Severino G; Del Zompo M
    Psychiatr Genet; 2008 Jun; 18(3):128-32. PubMed ID: 18496210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PDLIM5 gene and lithium prophylaxis: an association and gene expression analysis in Sardinian patients with bipolar disorder.
    Squassina A; Congiu D; Manconi F; Manchia M; Chillotti C; Lampus S; Severino G; Zompo MD
    Pharmacol Res; 2008 May; 57(5):369-73. PubMed ID: 18456508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
    J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsynonymous polymorphisms of the PDLIM5 gene association with the occurrence of both bipolar disorder and schizophrenia.
    Zain MA; Roffeei SN; Zainal NZ; Kanagasundram S; Mohamed Z
    Psychiatr Genet; 2013 Dec; 23(6):258-61. PubMed ID: 24064681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of olanzapine in the treatment of Japanese patients with bipolar I disorder in a current manic or mixed episode: a randomized, double-blind, placebo- and haloperidol-controlled study.
    Katagiri H; Takita Y; Tohen M; Higuchi T; Kanba S; Takahashi M
    J Affect Disord; 2012 Feb; 136(3):476-84. PubMed ID: 22134043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.
    Bridle C; Palmer S; Bagnall AM; Darba J; Duffy S; Sculpher M; Riemsma R
    Health Technol Assess; 2004 May; 8(19):iii-iv, 1-187. PubMed ID: 15147609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: post hoc analyses of 47-week data.
    Suppes T; Brown E; Schuh LM; Baker RW; Tohen M
    J Affect Disord; 2005 Dec; 89(1-3):69-77. PubMed ID: 16253344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.
    Niufan G; Tohen M; Qiuqing A; Fude Y; Pope E; McElroy H; Ming L; Gaohua W; Xinbao Z; Huichun L; Liang S
    J Affect Disord; 2008 Jan; 105(1-3):101-8. PubMed ID: 17531327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of open-label, 8-week trials of olanzapine monotherapy and topiramate augmentation of olanzapine for the treatment of pediatric bipolar disorder.
    Wozniak J; Mick E; Waxmonsky J; Kotarski M; Hantsoo L; Biederman J
    J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):539-45. PubMed ID: 19877978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-age children.
    Biederman J; Mick E; Hammerness P; Harpold T; Aleardi M; Dougherty M; Wozniak J
    Biol Psychiatry; 2005 Oct; 58(7):589-94. PubMed ID: 16239162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery and functional outcomes following olanzapine treatment for bipolar I mania.
    Chengappa KN; Hennen J; Baldessarini RJ; Kupfer DJ; Yatham LN; Gershon S; Baker RW; Tohen M
    Bipolar Disord; 2005 Feb; 7(1):68-76. PubMed ID: 15654934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olanzapine versus placebo in the treatment of adolescents with bipolar mania.
    Tohen M; Kryzhanovskaya L; Carlson G; Delbello M; Wozniak J; Kowatch R; Wagner K; Findling R; Lin D; Robertson-Plouch C; Xu W; Dittmann RW; Biederman J
    Am J Psychiatry; 2007 Oct; 164(10):1547-56. PubMed ID: 17898346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression and association analysis of LIM (PDLIM5) in major depression.
    Iga J; Ueno S; Yamauchi K; Numata S; Motoki I; Tayoshi S; Kinouchi S; Ohta K; Song H; Morita K; Rokutan K; Tanabe H; Sano A; Ohmori T
    Neurosci Lett; 2006 Jun; 400(3):203-7. PubMed ID: 16595163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
    J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asenapine versus olanzapine in acute mania: a double-blind extension study.
    McIntyre RS; Cohen M; Zhao J; Alphs L; Macek TA; Panagides J
    Bipolar Disord; 2009 Dec; 11(8):815-26. PubMed ID: 19832806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.